U.S. Markets
Elevance Health (ELV) discloses CMS moves to suspend the enrollment in Elevance Health Medicare Advantage drug plans; the sanctions are scheduled to take effect on March 31, 2026 unless CMS determines that the issues identified have been addressed
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
